SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Abbey Donald

(Last)

(First)

(Middle)

C/O CAREFUSION CORPORATION

3750 TORREY VIEW COURT

(Street)

SAN DIEGO

92130

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
11/02/2011

3. Issuer Name and Ticker or Trading Symbol
CAREFUSION Corp [ CFN ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	EVP, Quality Reg & Med Affairs

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	17,716	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Options (right to buy)⁽¹⁾	⁽²⁾	08/15/2014	Common Stock	365	$17.77	D
Options (right to buy)⁽¹⁾	⁽³⁾	08/15/2015	Common Stock	11,076	$31.9	D
Options (right to buy)	⁽⁴⁾	09/15/2016	Common Stock	39,516	$20.71	D
Restricted Stock Units⁽⁵⁾	⁽⁶⁾	⁽⁶⁾	Common Stock	7,080	$0⁽⁷⁾	D
Restricted Stock Units⁽⁵⁾	⁽⁸⁾	⁽⁸⁾	Common Stock	4,248	$0⁽⁷⁾	D
Options (right to buy)	⁽⁹⁾	08/16/2017	Common Stock	31,377	$22.59	D
Restricted Stock Units⁽⁵⁾	⁽¹⁰⁾	⁽¹⁰⁾	Common Stock	6,491	$0⁽⁷⁾	D
Restricted Stock Units⁽⁵⁾	⁽¹¹⁾	⁽¹¹⁾	Common Stock	19,478	$0⁽⁷⁾	D
Options (right to buy)	⁽¹²⁾	08/15/2018	Common Stock	30,700	$25.56	D
Restricted Stock Units⁽⁵⁾	⁽¹³⁾	⁽¹³⁾	Common Stock	4,475	$0⁽⁷⁾	D

Explanation of Responses:

1. Stock options originally granted by Cardinal Health, Inc. ("Cardinal Health"). Pursuant to the anti-dilution provisions of each stock option, the exercise price and number and kind of shares subject to each stock option were adjusted in conjunction with the spinoff of CareFusion Corporation from Cardinal Health on August 31, 2009.

2. Stock options granted in connection with the voluntary stock option exchange program conducted by Cardinal Health, with respect to stock options previously awarded by Cardinal Health. Pursuant to the stock option exchange program and the original terms of these stock options, these stock options are now fully exercisable.

3. Stock options granted subject to multi-year vesting based on original grant date. These stock options are now fully exercisable.

4. Stock options granted on September 15, 2009. These stock options are exercisable with respect to 26,344 shares and will vest as to 13,172 shares on September 15, 2012.

5. Each restricted stock unit represents a contingent right to receive one share of CareFusion common stock upon vesting.

6. Restricted stock units granted on September 15, 2009. The shares reflected above represent the unvested portion of the award, which will vest as to 7,080 shares on September 15, 2012.

7. Granted without payment by grantee.

8. Restricted stock units granted on September 15, 2009. The shares reflected above represent the unvested portion of the award, which will vest as to 4,248 shares on September 15, 2012.

9. Stock options granted on August 16, 2010. These stock options are exercisable with respect to 10,459 shares and will vest as to 10,459 shares on each of August 16, 2012 and August 16, 2013.

10. Restricted stock units granted on August 16, 2010. The shares reflected above represent the unvested portion of the award, which will vest as to 3,245 shares on August 16, 2012 and 3,246 shares on August 16, 2013.

11. Restricted stock units granted on August 16, 2010. This award will vest in full on August 16, 2013.

12. Stock options granted on August 15, 2011. These stock options will vest as to 10,233 shares on August 15, 2012, 10,233 shares on August 15, 2013, and 10,234 shares on August 15, 2014.

13. Restricted stock units granted on August 15, 2011. These restricted stock units will vest as to 1,491 shares on August 15, 2012, 1,492 shares on August 15, 2013, and 1,492 shares on August 15, 2014.

Remarks:

	Nathaniel Sisitsky, Attorney-in-Fact	11/10/2011
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.